Is 500mg of Metformin a Low Dose for Weight Loss?

Quick answer: Yes, 500mg is a low, entry-level dose of metformin. It is the standard starting point doctors use to limit stomach upset, and most people are slowly titrated up to 1,500mg to 2,000mg a day, which is where the modest weight effect actually shows. Even at full dose, metformin is not a true weight-loss drug. Trials show an average loss of roughly 4 to 7 pounds over a year, far below what GLP-1 medications like Wegovy or Zepbound deliver. So if you are asking whether 500mg is a low dose for weight loss, the honest answer is that it is both a low dose and a low-power tool for that job.

Metformin has been around since the 1950s, costs a few dollars a month, and is one of the most prescribed drugs on earth. People hear it can “cause weight loss” and assume that means it works like the newer injectables. It does not. Understanding what 500mg really does, where the dose ceiling sits, and who actually benefits will save you months of disappointment on the scale.

Is 500mg of metformin a low dose, and what is the full dosing range?

Yes, 500mg once daily is the lowest standard dose of metformin and is almost always a starting point, not a destination. Clinicians begin here on purpose because metformin’s main side effect, gastrointestinal distress, is dose-dependent. Start low, let the gut adapt, then climb.

The typical titration for immediate-release metformin looks like this:

• Week 1 to 2: 500mg once a day with a meal.
• Week 3 onward: 500mg twice a day (1,000mg total).
• Following weeks: step up by 500mg every one to two weeks as tolerated.
• Common target: 1,500mg to 2,000mg a day, usually split into two or three doses.
• Maximum: 2,550mg a day for immediate-release, 2,000mg for the extended-release (ER) version.

So when someone says they are “on metformin for weight,” 500mg means they are barely out of the gate. The doses that nudge the scale in studies sit at 1,500mg and above. If you have been parked at 500mg for months and seen nothing, that is expected, not a failure of the drug.

Dose	What it is	Typical use
500mg/day	Low starter dose	First 1 to 2 weeks, gut adaptation
1,000mg/day	Low-to-moderate	Common after titration, some glucose effect
1,500mg/day	Moderate, often effective	Where most metabolic benefit begins
2,000mg/day	Standard full dose	Most common maintenance dose for diabetes and PCOS
2,550mg/day	Maximum (IR)	Reserved, higher side-effect risk

Immediate-release vs extended-release: why the formulation matters

Metformin comes in two forms, and the difference is not trivial for anyone who plans to stay on it. Immediate-release (IR) hits quickly and is usually split into two or three doses a day, which is cheaper but harder on the stomach and easier to forget. Extended-release (ER) dissolves slowly, is typically taken once daily with the evening meal, and causes noticeably less nausea and diarrhea. Many clinicians move people who struggle with GI side effects from IR to ER rather than abandoning the drug, and adherence tends to improve simply because a once-a-day pill is easier to keep taking. If your only experience of metformin was a rough week on the immediate-release version, that is worth raising with your prescriber, because the formulation, not the drug, may have been the problem.

How much weight does metformin actually cause you to lose?

Not much, and the number surprises people. Across large reviews, metformin produces an average weight loss of about 4 to 7 pounds (roughly 2 to 3 kg) over six to twelve months at full dose, and a chunk of users lose nothing at all. The landmark Diabetes Prevention Program, which followed thousands of high-risk adults, found metformin users lost an average of around 4 to 5 pounds and, notably, kept some of it off for years, which is rare. But that is a trickle, not a flood.

Compare that honestly to the GLP-1 class. In the STEP trials, semaglutide (Wegovy) drove an average loss near 15% of body weight. In the SURMOUNT trials, tirzepatide (Zepbound) hit roughly 20% or more at the higher doses. For a 220-pound person, that is the difference between losing about 5 to 7 pounds on metformin and 30 to 45 pounds on a GLP-1. The mechanisms are not in the same league.

Metformin works mostly by lowering how much glucose your liver pumps out and by improving insulin sensitivity, with a side effect of mild appetite reduction in some people. It does not slow stomach emptying or act strongly on the brain’s appetite centers the way GLP-1 drugs do. For a deeper look at the mechanism, see does Metformin cause weight loss and the conditions under which it helps at all.

Who does metformin actually help lose weight?

Metformin earns its keep in people whose weight is tied to insulin resistance, not in metabolically healthy people who simply want to drop pounds. The drug targets a specific problem, and if you do not have that problem, you should not expect a result.

The groups who tend to see real benefit:

• PCOS: Women with polycystic ovary syndrome often have high insulin and androgens. Metformin can improve insulin sensitivity, sometimes restore ovulation, and contribute modest weight loss. This is one of its strongest off-label uses.
• Prediabetes and insulin resistance: If your fasting insulin and HbA1c are creeping up, metformin can blunt the slide toward type 2 diabetes and trim a few pounds along the way.
• Antipsychotic-associated weight gain: Metformin is used to offset weight gain from certain psychiatric medications.
• Stubborn weight with metabolic markers: People whose labs show insulin resistance even at a “normal” weight.

Here is the insider point most people miss: whether metformin will do anything for you is almost entirely a question of your lab numbers, not your goal weight. A person with fasting insulin of 18 and an HbA1c of 6.0 is a candidate. A person with perfect insulin sensitivity who just wants to lose 15 vanity pounds is wasting a prescription. The drug is a tool for a metabolic lock, and you need to know if you have that lock before you reach for the key.

Which labs predict whether metformin will actually work for you?

Because metformin only pulls the insulin-resistance lever, a few numbers tell you in advance whether it has any lever to pull. These are the markers clinicians look at, and they are worth knowing before you spend three months hoping:

• Fasting insulin: the most direct signal. A high fasting insulin with normal glucose is the classic early insulin-resistance pattern, and it is exactly the state metformin is built for. A low-normal fasting insulin suggests the drug has little to do.
• HbA1c: your average blood sugar over about three months. Creeping into the prediabetes range (roughly 5.7 to 6.4 percent) is a signal metformin may help slow the slide.
• HOMA-IR: a simple calculation from fasting glucose and fasting insulin that estimates insulin resistance. It is a cleaner readout than glucose alone.
• Triglyceride-to-HDL ratio: a rough, inexpensive surrogate for insulin resistance you can read straight off a standard lipid panel. A high ratio often travels with the metabolic pattern metformin addresses.

Consider a common real-world case. A 32-year-old woman with PCOS, irregular cycles, fasting insulin of 19, and an HbA1c of 6.0 is close to a textbook candidate, and her clinician might reasonably titrate metformin toward a full dose while tracking those same numbers. Contrast that with a lean 40-year-old man with a fasting insulin of 4 and a normal HbA1c who wants to drop ten pounds. Metformin has almost nothing to act on in his case, and the scale will confirm it. The lab work, not the goal weight, decides the outcome.

This is the practical reason to measure before you medicate. Getting fasting insulin, HbA1c, a lipid panel, thyroid markers, and sex hormones in a single draw shows you which lever is actually stuck, so you and your clinician can choose the tool that matches it instead of guessing.

500mg metformin vs higher doses vs GLP-1: a realistic comparison

The clearest way to set expectations is to line up the options by what they actually deliver, what they cost in 2026, and who they fit.

Option	Avg weight loss	FDA status for weight	Rough 2026 cost (cash)	Best for
Metformin 500mg/day	Minimal	Not approved (off-label)	$4 to $15/month	Starter dose, gut adaptation
Metformin 1,500 to 2,000mg/day	~4 to 7 lbs/year	Not approved (off-label)	$4 to $20/month	Insulin resistance, PCOS, prediabetes
Wegovy (semaglutide)	~15% body weight	FDA-approved for weight	~$500 to $650/month, often less with coverage	Obesity, strong appetite drive
Zepbound (tirzepatide)	~20%+ body weight	FDA-approved for weight	~$550 to $700/month, vials cheaper	Higher weight-loss target
Compounded semaglutide/tirzepatide	Similar to brand if dosed right	NOT FDA-approved (legally prescribed)	~$150 to $300/month	Cost-sensitive patients under clinician care

One precision point that matters: compounded semaglutide and tirzepatide are not FDA-approved products. They are made by licensed compounding pharmacies and prescribed by clinicians, which is legal, but it is not the same regulatory status as Wegovy or Zepbound. Anyone telling you compounded GLP-1 is “FDA approved” is wrong. The right way to use it is through a real clinician who reviews your labs and supervises the dose, not a sketchy website that ships vials with no oversight.

Metformin pairs reasonably with other approaches too. People sometimes ask how it stacks against other off-label options like does Wellbutrin cause weight loss or the SGLT2 inhibitors covered in does Jardiance cause weight loss. Each works on a different lever, and the right one depends on your metabolic picture.

What stalls people on metformin (common mistakes)

Most metformin disappointment comes from a handful of predictable errors, not from the drug failing. Fix these before you write it off.

1. Staying at 500mg forever. This is the single biggest one. 500mg is a starter dose. If your doctor never titrated you up and you are judging the drug on its lowest setting, you never gave it a fair test.
2. Expecting GLP-1 results. People see Wegovy testimonials and assume metformin is the cheap version. It is not. A 4 to 7 pound average is the ceiling, not the floor.
3. Quitting over week-one nausea. The GI side effects (loose stools, cramping, gas) usually fade in two to four weeks as the gut adapts. Switching to the extended-release version and taking it with the largest meal solves most cases.
4. Taking it for a problem they do not have. If your insulin sensitivity is normal, metformin has almost no lever to pull. You will lose nothing and blame yourself.
5. Ignoring the thyroid and hormones. A stalled scale is often a thyroid issue (subclinical hypothyroidism), perimenopause, or high cortisol, none of which metformin touches. Pinning a stall on the wrong organ wastes months.

That last point is the through-line. When weight will not move, the failure is usually guessing instead of measuring. Metformin is a guess unless your labs say insulin resistance is the driver. The smarter sequence is to test fasting insulin, HbA1c, thyroid (TSH, free T4, free T3) and sex hormones first, then choose the tool that matches the result. If the scale will not budge no matter how clean you eat, it is usually worth seeing your actual numbers before adding another pill. Here is how a full-body panel works.

What a realistic metformin timeline looks like

Setting expectations by month prevents most of the disappointment people feel. This is the general arc clinicians describe, not a promise, since response varies widely:

• Weeks 1 to 4: the adjustment window. Expect the gut side effects, not weight change. This is when most people quit, usually too early.
• Months 2 to 3: once titrated toward a full dose, fasting glucose and insulin often improve before the scale does. Many responders notice reduced snacking or blood-sugar crashes here.
• Months 3 to 6: if metformin is going to move your weight, this is where the modest few pounds tend to show, layered on top of diet and activity, not instead of them.
• Beyond 6 months: if a proper dose has produced nothing on the scale or your labs, that is strong evidence insulin resistance was not your driver, and it is time to reassess with your clinician rather than push the dose higher.

The trap is judging the drug at week two on a starter dose. The trials that show any benefit ran for six to twelve months at a full dose, so a fair test takes patience and a clinician willing to titrate.

Side effects of metformin and how to manage them

Metformin is remarkably safe, which is part of why it is so widely prescribed, but it has a clear side-effect profile worth knowing. The most common, by far, are gastrointestinal: nausea, diarrhea, abdominal cramping, and a metallic taste, all dose-dependent and worst in the first few weeks.

How clinicians blunt these:

• Switch to extended-release (ER). The ER formulation releases slowly and causes far less GI upset than immediate-release.
• Take it with food, ideally the largest meal of the day.
• Titrate slowly. Going from 500mg to 2,000mg in one jump is asking for a bad week.

Two issues matter beyond the gut. Long-term metformin use can lower vitamin B12, so periodic B12 checks are smart on extended therapy. And the rare but serious risk is lactic acidosis, which is why metformin is avoided in people with significant kidney or liver disease. This is one reason to start any medication, including metformin, through a clinician who checks your kidney function first. Talk to a clinician before starting or stopping a medication, especially if you have kidney or liver concerns.

Two situational cautions are worth knowing. Metformin is usually paused around procedures that use iodinated contrast dye and around major surgery, because both can stress the kidneys, so tell any care team you are on it. And while an occasional drink is generally fine, heavy alcohol use raises the risk of the rare lactic acidosis and is best avoided. None of this makes metformin dangerous for the right person. It simply underlines why it belongs in a supervised plan rather than a self-directed one.

When an on-label GLP-1 path beats off-label experimentation

If your real goal is meaningful weight loss and your labs point to obesity or strong appetite drive rather than pure insulin resistance, metformin is the wrong primary tool, and the smarter move is an on-label GLP-1 through a supervised clinician. Self-experimenting by stacking 500mg of metformin with random supplements, or worse, ordering peptides off the gray market, is how people waste a year and risk their health.

The honest decision tree:

• Insulin resistance or PCOS, modest goal: Metformin titrated to 1,500 to 2,000mg is reasonable, often as a first step.
• Obesity or large weight-loss goal: An FDA-approved GLP-1 (Wegovy, Zepbound) is the evidence-based path. Compounded versions can lower cost but only under clinician supervision.
• Unclear picture: Test first. Get the metabolic and hormone panel, then let the numbers choose the drug.

People also compare metformin to other glucose-lowering drugs that happen to trim weight. If you are curious how the SGLT2 class performs, how rapid is weight loss with Farxiga walks through a different mechanism, and for the seizure-medication route there is how to take Topiramate for weight loss. None of these is a substitute for matching the drug to your actual biology.

The point is not that metformin is bad. It is cheap, safe, well-studied, and genuinely useful for the right person. The point is that 500mg is a low dose of a low-power weight tool, and the people who succeed are the ones who measure their metabolism, pick the matching medication, and run it through a real clinician instead of guessing in the dark.

FAQ

Is 500mg of metformin enough to lose weight?

For most people, no. 500mg is a starter dose chosen to ease the gut into the drug, and the modest weight effect seen in studies appears at 1,500mg to 2,000mg a day. If you stay at 500mg, expect little to no scale movement.

How long does it take to lose weight on metformin?

Weight changes are slow and small. People who respond usually see a few pounds over several months once they reach a full dose of 1,500mg or more. If nothing has happened after three to six months at a proper dose, metformin is probably not your answer.

Will I gain the weight back if I stop metformin?

Often, yes, if the underlying insulin resistance returns and lifestyle has not changed. Metformin treats a metabolic state rather than curing it, so stopping the drug usually reverses its modest effect over time, similar in principle to how people regain weight after stopping a GLP-1.

Can metformin cause weight gain?

No, metformin does not cause weight gain. It is weight-neutral to mildly weight-reducing, which is one reason it is preferred over some older diabetes drugs that do pack on pounds. Any weight gain on metformin is from diet, other medications, or an untreated condition, not the drug itself.

What is the maximum dose of metformin for weight loss?

The maximum is 2,550mg a day for immediate-release metformin and 2,000mg for extended-release. Most people for weight or PCOS sit at 1,500mg to 2,000mg. Pushing to the maximum increases side effects without a large extra weight benefit.

Is metformin better than Ozempic for weight loss?

No. Ozempic and its weight-approved sibling Wegovy (both semaglutide) produce far more weight loss, around 15% of body weight in the STEP trials, versus a few pounds for metformin. Ozempic is FDA-approved for diabetes and used off-label for weight, while Wegovy is approved specifically for weight management.

Do I need a prescription and labs to take metformin?

Yes, metformin is prescription-only in the US, and a responsible clinician will check your kidney function and likely your blood glucose and insulin before prescribing it. This screening exists because metformin is avoided in significant kidney or liver disease.

Why am I not losing weight on metformin even at a full dose?

The most common reason is that insulin resistance is not actually your problem. A stalled scale can be driven by thyroid issues, perimenopause, high cortisol, or simple calorie intake, none of which metformin addresses. Testing your fasting insulin, HbA1c, thyroid, and hormones usually reveals the real lever.

Can I take metformin if I do not have diabetes?

Yes, and this is common. Metformin is prescribed off-label for PCOS, prediabetes, insulin resistance, and to offset weight gain from certain psychiatric medications. Off-label simply means the FDA has not formally approved it for that specific use, not that it is improper. It still requires a prescription and a clinician who has checked that it is appropriate for you.

Does metformin work without diet and exercise?

Barely. Metformin is a lever, not an engine. Its modest effect shows up on top of nutrition and activity changes, not as a replacement for them. People who expect the pill to do the work while nothing else changes are the ones most likely to report it did nothing.

Is 1,000mg of metformin enough for weight loss?

It is better than 500mg but still below where the weight effect is most consistent in studies, which is generally 1,500mg and up. Some people do respond at 1,000mg, especially with strong insulin resistance, but many clinicians continue titrating if it is tolerated. Your labs and side effects, guided by your prescriber, decide where you land.

Should I switch from metformin to a GLP-1?

That is a clinician decision based on your labs and goals, not a swap you make on your own. If your picture is obesity or a large weight-loss target rather than pure insulin resistance, an on-label GLP-1 under supervision is usually the stronger tool. The safe path is a clinician who reads your panel and matches the medication to it.